Top 15 Medical Devices Stocks by Marvin Score
Marvin's rules pick 15 Medical - Devices stocks, led by Globus Medical, TransMedics and DexCom. They are ranked by Overall score against other device makers, as of October 2026.
Medical device companies make the equipment, implants and monitoring tools used in patient care. This list shows the 15 device companies that score highest on Marvin's Overall measure, which blends business quality with opportunity. Globus Medical, TransMedics and DexCom come out on top.
Look beyond the ranking. Some companies here have high margins and slow growth, while others grow quickly but earn thin profits. Each blurb below points out one figure that is weaker or missing so you can see the trade-off.
Scores only describe how a company compares with other device companies today. They are not forecasts or advice.
The list
How Marvin ranked these stocks
Marvin included companies above about $300 million in size and ranked them by Marvin scores from 0 to 100, with the highest Overall score first. The scores are relative to each company's own industry, here Medical - Devices. A high score means the company looks strong next to other device makers, not next to every stock in the market.
Companies above about $300 million in size, ranked by Marvin scores (0-100, relative to each company's own industry). The Medical - Devices industry, highest Overall score first.
The stocks, one by one
Globus Medical, Inc. GMED
Globus Medical leads the list with an overall score of 96. Revenue grew 16.7% last fiscal year, and an operating margin of 20.3% and free cash flow margin of 24.0% point to solid profitability. Caution: return on equity is a modest 11.2%, and no debt figure is available.
TransMedics Group, Inc. TMDX
TransMedics shows strong growth, with revenue up 37.1% and a return on equity of 29.3%. Caution: its operating margin of 12.2% is thinner than those of several larger peers on this list, and no debt-to-equity figure is available.
DexCom, Inc. DXCM
DexCom combines an operating margin of 22.9%, a free cash flow margin of 28.3% and a return on equity of 38.1%, all signs of strong profitability. Caution: its opportunity score of 72 is much lower than its quality score of 95.
Boston Scientific Corporation BSX
Boston Scientific grew revenue 19.9% and has a gross margin of 69.9%, with a debt-to-equity ratio of 0.51, which looks moderate. Caution: its opportunity score of 69 sits well below its quality score of 93.
UFP Technologies, Inc. UFPT
UFP Technologies grew revenue 19.5%, has an operating margin of 15.3% and carries little debt, with debt-to-equity of 0.29. Caution: its gross margin of 28.5% is far lower than most peers here, and no free cash flow figure is available.
Insulet Corp. PODD
Insulet grew revenue 30.7%, earns a gross margin of 71.1% and posts a return on equity of 26.4%. Caution: its free cash flow margin of 9.6% is modest next to its sales growth, and debt-to-equity is 0.67.
Tactile Systems Technology, Inc. TCMD
Tactile Systems carries very little debt, with debt-to-equity of 0.06, and has a high gross margin of 76.8%. Caution: its operating margin of 10.0% and free cash flow margin of 7.7% are thin, and revenue growth was 12.5%.
IRadimed Corporation IRMD
IRadimed stands out for profitability, with an operating margin of 31.9%, a free cash flow margin of 29.1% and a gross margin of 75.9%. Caution: its opportunity score of 53 is far below its quality score of 94, and no debt figure is available.
Edwards Lifesciences Corporation EW
Edwards Lifesciences has a gross margin of 77.8%, very little debt (debt-to-equity of 0.07) and a quality score of 97. Caution: revenue growth of 11.5% is modest, and its opportunity score of 22 is the weaker side of its profile.
Stryker Corporation SYK
Stryker shows an operating margin of 21.4% and a free cash flow margin of 18.2%, with debt-to-equity of 0.65. Caution: revenue growth of 11.2% is modest, and its opportunity score is only 48.
Zimmer Biomet Holdings, Inc. ZBH
Zimmer Biomet has a gross margin of 69.9% and a free cash flow margin of 17.9%, with debt-to-equity of 0.59. Caution: revenue growth of 7.2% and return on equity of 6.4% are among the weaker figures on this list.
Inspire Medical Systems, Inc. INSP
Inspire Medical Systems has a very high gross margin of 86.1%, revenue growth of 13.6% and a return on equity of 16.4%. Caution: its operating margin of 6.0% is thin, and no debt figure is available.
Abbott Laboratories ABT
Abbott Laboratories has an operating margin of 17.1% and a free cash flow margin of 16.3%, with debt-to-equity of 0.65. Caution: revenue growth of 5.7% is the slowest on this list, and its opportunity score is 14.
Penumbra, Inc. PEN
Penumbra grew revenue 17.5%, with a gross margin of 67.8% and a free cash flow margin of 14.3%. Caution: its opportunity score of 34 is the lowest on the list, and no debt figure is available.
Delcath Systems, Inc. DCTH
Delcath Systems grew revenue 129.1%, with a gross margin of 87.1% and a free cash flow margin of 18.3%. Caution: its operating margin is negative at -1.9% and return on equity is only 0.4%, so profits look less established.
Common questions
What does Marvin's Overall score mean?
The Overall score runs from 0 to 100 and summarizes how a company compares with others in its industry today. Marvin's quality and opportunity scores feed into it. It describes the present and is not a forecast.
Does a higher rank mean a better investment?
No. The rank shows how a company scores against other device makers on Marvin's measures. It does not say whether a stock will do well, and it is not advice. Two companies with similar scores can have very different strengths, such as fast growth versus high margins.
Why do some stocks have no debt figure or free cash flow figure?
Marvin only shows a figure when the data is available for that company. Where a debt-to-equity ratio or free cash flow margin is missing, the blurb leaves it out, and you may want to check the company's own financial reports.
Keep reading
- Top 20 Medical Stocks Ranked by Marvin Scores
- Top 15 Healthcare Stocks Right Now, Ranked by Marvin Scores
- Top 15 Healthcare Companies With the Strongest Businesses
- Top 20 Defensive Stocks Ranked by Marvin Business Quality
Free account. Build your own AI-made watchlists, follow Marvin's scores and share lists.
Create a free account
Marvin's scores (0-100) compare each company with others in its industry today. Growth and margin figures come from SEC filings. This is general information, not personal investment advice or a recommendation to buy or sell anything. Do your own research.